W. Frank Peacock, MD, FACEP, Vice Chair, Emergency Medicine Institute, Cleveland Clinic Foundation, and the study’s Primary Investigator, said: “Outcomes in patients presenting to the emergency department with acute shortness of breath are related to appropriate and timely therapy. When therapy is delayed or inappropriate, the acute mortality rate is increased. Our data suggest that an early and accurate heart failure diagnosis can be determined by measuring orthostatic hemodynamic changes using BIOREACTANCE Technology.”
Daniel Burkhoff, M.D., Ph.D., added, “This study illustrates the frontline clinical utility of NICOM System BIOREACTANCE Technology noninvasive flow-based hemodynamic monitoring, and the great potential of using dynamic functional hemodynamic testing at the bedside to improve the diagnosis of heart failure. It is easily performed by clinical staff, provides immediate results and is very cost-effective.”
